Atlas Trials

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Clinical trial NCT01092481 · UNKNOWN

Trial details

NCT number
NCT01092481
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Colon Cancer
Start date
2010-01-26
Primary completion
2019-12-01
Enrollment
1580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.